Full Year 2024 Revenio Group Oyj Earnings Call Transcript
Key Points
- Revenio Group Oyj (REVXF) reported strong cash flow for Q4 2024, ending with a positive cash flow of EUR 9.8 million, up from EUR 5.2 million in the previous year.
- The company achieved over 7% growth in net sales for the full year, reaching EUR 103.5 million.
- Revenio Group Oyj (REVXF) successfully launched several new products, including the iCare ST500 and the iCare MAIA device, contributing to their competitive product portfolio.
- The company maintained a strong balance sheet with an equity ratio that has been growing, and net gearing below zero for the last five years.
- Revenio Group Oyj (REVXF) has been able to manage supply chain challenges effectively, with no delivery issues reported in 2024.
- Q4 2024 net sales were down 1.1% when adjusted for currency, indicating some challenges in maintaining sales momentum.
- The company faced cost pressures, including salary inflation and increased expenses related to IT and marketing.
- FDA approval delays for the iCare MAIA device have impacted the timeline for market entry, pushing potential sales contributions to later than originally planned.
- Revenio Group Oyj (REVXF) has a broad guidance range for 2025 due to uncertainties in the geopolitical and economic environment, including potential tariffs affecting US sales.
- The company's profitability, while strong, has decreased from 30% to 25% EBIT margin, indicating some margin compression.
Welcome to revenue 2024 financial statement release and special thanks for all the people who are here, face to face at Sano Matalo and of course for all of you who are behind the webcast.
My name is Joni Toyella. I'm, the group CEO for Revenue, and, today, together with me, we also have our CFO Robin Poulinen.
For today's menu is looking like this, so we have 5 topics, so I'm going to start with the business highlights.
Then I'm going to recap this strategy and then also look back to the year 2024, how we have been able to execute the strategy. Then Robin is going to take over to go through the Q4 and the overall 2024 numbers and then we are going to give at the end the financial guidance and Robin is going to conclude, with the topic revenue.
As an investment and then we move to the Q&A at the end.
Q4 net sales EUR 30.5 million. So, this is reported sales. So, if you look at the currency adjusted sales terms, so we were down 1.1%, operating profit in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
